Nanoform News and Resources

Nanoform Finland has announced a pre-clinical development agreement with the plasma-derived therapies business unit of Takeda to develop new formulations for the treatment of rare conditions. This collaboration will leverage Nanoform’s nanoforming technology to enhance the performance of plasma-derived therapies.